Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Alcon agrees acquisition of Transcend Medical

Alcon agrees acquisition of Transcend Medical

18th February 2016

Alcon has announced the acquisition of Transcend Medical, a move that will strengthen its position in the glaucoma treatment market.

The US-based Transcend Medical is focused on the development of minimally-invasive surgical devices to treat glaucoma, recently creating a micro-stent to treat mild to moderate forms of the condition.

This device is implanted just below the surface of the eye and is designed to treat less severe glaucoma by enhancing the natural drainage pathways of the eye with minimal tissue disruption.

Having demonstrated its benefits in clinical trials, the stent has been granted European CE Mark approval and is awaiting the green light from the US Food and Drug Administration.

Mike Ball, chief executive officer of Alcon, said: "If approved, it will provide a less invasive means of lowering intraocular pressure than traditional invasive glaucoma surgery, with the goal of lowering the dependency of topical ocular medication."

Mr Ball was appointed as the head of Alcon last month, succeeding Jeff George.ADNFCR-8000103-ID-801812854-ADNFCR

We currently have 6 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.